296 related articles for article (PubMed ID: 32761232)
1. Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses.
Phan V; Ito T; Inaba M; Azuma Y; Kibata K; Inagaki-Katashiba N; Tanaka A; Satake A; Nomura S
Blood Adv; 2020 Aug; 4(15):3572-3585. PubMed ID: 32761232
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide.
Yamamoto K; Kitawaki T; Sugimoto N; Fujita H; Kawase Y; Takaori-Kondo A; Kadowaki N
Immunol Lett; 2019 Jul; 211():41-48. PubMed ID: 31141702
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models.
Cho SF; Lin L; Xing L; Li Y; Wen K; Yu T; Hsieh PA; Munshi N; Wahl J; Matthes K; Friedrich M; Arvedson T; Anderson KC; Tai YT
Blood Adv; 2020 Sep; 4(17):4195-4207. PubMed ID: 32898244
[TBL] [Abstract][Full Text] [Related]
4. Intracellular glutathione redox status in human dendritic cells regulates IL-27 production and T-cell polarization.
Kamide Y; Utsugi M; Dobashi K; Ono A; Ishizuka T; Hisada T; Koga Y; Uno K; Hamuro J; Mori M
Allergy; 2011 Sep; 66(9):1183-92. PubMed ID: 21545428
[TBL] [Abstract][Full Text] [Related]
5. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
6. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization.
Chu DK; Llop-Guevara A; Walker TD; Flader K; Goncharova S; Boudreau JE; Moore CL; Seunghyun In T; Waserman S; Coyle AJ; Kolbeck R; Humbles AA; Jordana M
J Allergy Clin Immunol; 2013 Jan; 131(1):187-200.e1-8. PubMed ID: 23006545
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells.
Endo S; Amano M; Nishimura N; Ueno N; Ueno S; Yuki H; Fujiwara S; Wada N; Hirata S; Hata H; Mitsuya H; Okuno Y
Biochem Biophys Res Commun; 2016 Jan; 469(2):236-42. PubMed ID: 26657848
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
Fuchs O
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):51-78. PubMed ID: 29788898
[TBL] [Abstract][Full Text] [Related]
9. The T
Zheng R; Chen FH; Gao WX; Wang D; Yang QT; Wang K; Lai YY; Deng J; Jiang LJ; Sun YQ; Shi JB
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):474-482.e1. PubMed ID: 28132739
[TBL] [Abstract][Full Text] [Related]
10. CCL17 production by dendritic cells is required for NOD1-mediated exacerbation of allergic asthma.
Ait Yahia S; Azzaoui I; Everaere L; Vorng H; Chenivesse C; Marquillies P; Duez C; Delacre M; Grandjean T; Balsamelli J; Fanton d'Andon M; Fan Y; Ple C; Werts C; Boneca IG; Wallaert B; Chamaillard M; Tsicopoulos A
Am J Respir Crit Care Med; 2014 Apr; 189(8):899-908. PubMed ID: 24661094
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of CD86 and reduced production of IL-12 and IL-10 by monocyte-derived dendritic cells from allergic asthmatics and their effects on Th1- and Th2-type cytokine balance.
Chen XQ; Yang J; Hu SP; Nie HX; Mao GY; Chen HB
Respiration; 2006; 73(1):34-40. PubMed ID: 16106114
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma.
Barley K; He W; Agarwal S; Jagannath S; Chari A
Leuk Lymphoma; 2016 Nov; 57(11):2510-5. PubMed ID: 26943456
[TBL] [Abstract][Full Text] [Related]
13. Th2 cell differentiation from naive CD4
Hirata H; Yukawa T; Tanaka A; Miyao T; Fukuda T; Fukushima Y; Kurasawa K; Arima M
Clin Exp Allergy; 2019 Apr; 49(4):474-483. PubMed ID: 30431203
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Notch ligand Delta-like-1 by dendritic cells enhances their immunoregulatory capacity and exerts antiallergic effects on Th2-mediated allergic asthma in mice.
Lee CC; Lin CL; Leu SJ; Lee YL
Clin Immunol; 2018 Feb; 187():58-67. PubMed ID: 29038036
[TBL] [Abstract][Full Text] [Related]
15. TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen.
Tan AM; Chen HC; Pochard P; Eisenbarth SC; Herrick CA; Bottomly HK
J Immunol; 2010 Apr; 184(7):3535-44. PubMed ID: 20194715
[TBL] [Abstract][Full Text] [Related]
16. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
[TBL] [Abstract][Full Text] [Related]
17. Impaired Tumor-Necrosis-Factor-α-driven Dendritic Cell Activation Limits Lipopolysaccharide-Induced Protection from Allergic Inflammation in Infants.
Bachus H; Kaur K; Papillion AM; Marquez-Lago TT; Yu Z; Ballesteros-Tato A; Matalon S; León B
Immunity; 2019 Jan; 50(1):225-240.e4. PubMed ID: 30635238
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
Front Immunol; 2018; 9():977. PubMed ID: 29780393
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract][Full Text] [Related]
20. IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand.
Murakami-Satsutani N; Ito T; Nakanishi T; Inagaki N; Tanaka A; Vien PTX; Kibata K; Inaba M; Nomura S
Allergol Int; 2014; 63(3):443-455. PubMed ID: 28942933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
